Generation and characterisation of an animal model for age-related macular degeneration

年龄相关性黄斑变性动物模型的生成和表征

基本信息

  • 批准号:
    nhmrc : 211977
  • 负责人:
  • 金额:
    $ 15.11万
  • 依托单位:
  • 依托单位国家:
    澳大利亚
  • 项目类别:
    NHMRC Project Grants
  • 财政年份:
    2002
  • 资助国家:
    澳大利亚
  • 起止时间:
    2002-01-01 至 2004-12-31
  • 项目状态:
    已结题

项目摘要

Age-Related Macular Degeneration (AMD) is the leading cause of irreversible blindness in the aged population in the developed world, and it is one of the least understood retinal diseases. AMD is a slow, progressive and painless condition that affects the macula, the small central part of the retina that allows one to see fine detail clearly. With the ever-increasing human life expectancy, the prevalence of AMD (15-30%) in the age group of over 75 years will significantly increase, causing enormous social and financial problems for the community. In spite of the significance of this problem, the exact cause of AMD is not yet known, and there is no permanent effective treatment or cure for the condition. One of the major obstacles hindering any advances towards the development of intervention strategies or therapies is the lack of an appropriate animal model. Currently, the animal models that are available for ocular diseases do not fit the human AMD situation. This project aims to characterize the first animal model for retinal degeneration caused by abnormal functioning of the retinal pigment epithelial cells (RPE). The main role of RPE cells is the phagocytosis and digestion of the continuously growing and shed light receptor segments in the eye. Their normal functioning therefore is vital to maintaining good vision. The availability of such an animal model will allow us to learn more about the changes that might occur in the eye leading to the development of AMD and to design strategies to prevent or delay progression of the condition.
视网膜相关性黄斑变性(AMD)是发达国家老年人群中不可逆失明的主要原因,并且是最不了解的视网膜疾病之一。AMD是一种缓慢的,渐进的和无痛的条件,影响黄斑,视网膜的小中心部分,使一个人可以清楚地看到细节。随着人类预期寿命的不断延长,75岁以上年龄组中AMD的患病率(15-30%)将显著增加,给社区带来巨大的社会和经济问题。尽管这个问题的重要性,AMD的确切原因尚不清楚,并且对于该病症没有永久有效的治疗或治愈。阻碍干预策略或疗法发展的主要障碍之一是缺乏适当的动物模型。目前,可用于眼部疾病的动物模型不适合人类AMD情况。该项目旨在描述第一个由视网膜色素上皮细胞(RPE)功能异常引起的视网膜变性动物模型。RPE细胞的主要作用是吞噬和消化眼睛中不断生长和脱落的光受体片段。因此,它们的正常功能对于保持良好的视力至关重要。这种动物模型的可用性将使我们能够更多地了解眼睛中可能发生的导致AMD发展的变化,并设计预防或延迟病情进展的策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dr Chooi-May Lai其他文献

Dr Chooi-May Lai的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Dr Chooi-May Lai', 18)}}的其他基金

Long-term human response following subretinal injection of recombinant adenoassociated virus-sFlt-1 vector
视网膜下注射重组腺相关病毒-sFlt-1载体后的长期人体反应
  • 批准号:
    nhmrc : 1010405
  • 财政年份:
    2011
  • 资助金额:
    $ 15.11万
  • 项目类别:
    NHMRC Project Grants
Preclinical in vivo evaluation of sFLT secretion gene therapy for retinal and choroidal neovascularisation
sFLT 分泌基因治疗视网膜和脉络膜新生血管的临床前体内评估
  • 批准号:
    nhmrc : 353599
  • 财政年份:
    2005
  • 资助金额:
    $ 15.11万
  • 项目类别:
    NHMRC Project Grants
Gene Therapy for the treatment of retinal dystrophy in the RPE65 knockout mouse using rAAV virus mediated gene therapy.
使用 rAAV 病毒介导的基因疗法治疗 RPE65 敲除小鼠的视网膜营养不良。
  • 批准号:
    nhmrc : 139036
  • 财政年份:
    2001
  • 资助金额:
    $ 15.11万
  • 项目类别:
    NHMRC Project Grants

相似海外基金

Characterisation of a novel protein toxin family secreted by the animal and human pathogen Staphylococcus aureus
动物和人类病原体金黄色葡萄球菌分泌的新型蛋白质毒素家族的表征
  • 批准号:
    2753148
  • 财政年份:
    2022
  • 资助金额:
    $ 15.11万
  • 项目类别:
    Studentship
Functional characterisation of genetic variants influencing human food preferences using bioinformatics and animal models
使用生物信息学和动物模型对影响人类食物偏好的遗传变异进行功能表征
  • 批准号:
    1939154
  • 财政年份:
    2017
  • 资助金额:
    $ 15.11万
  • 项目类别:
    Studentship
Molecular and Biological Characterisation of Novel Genetic Markers Associated to the Common of Alzheimer's Disease in a Population Isolate from Eastern Canada
与加拿大东部人群中常见阿尔茨海默病相关的新型遗传标记的分子和生物学特征
  • 批准号:
    238124
  • 财政年份:
    2011
  • 资助金额:
    $ 15.11万
  • 项目类别:
    Operating Grants
Pathophysiology and Characterisation of NAFLD
NAFLD 的病理生理学和特征
  • 批准号:
    7591261
  • 财政年份:
    2005
  • 资助金额:
    $ 15.11万
  • 项目类别:
Pathophysiology and Characterisation of NAFLD
NAFLD 的病理生理学和特征
  • 批准号:
    7391610
  • 财政年份:
    2005
  • 资助金额:
    $ 15.11万
  • 项目类别:
Characterisation of the molecular mechanisms of colonisation of probiotic bacteria in an in vivo animal model
体内动物模型中益生菌定植的分子机制的表征
  • 批准号:
    229670-2000
  • 财政年份:
    2003
  • 资助金额:
    $ 15.11万
  • 项目类别:
    Discovery Grants Program - Individual
Characterisation of the molecular mechanisms of colonisation of probiotic bacteria in an in vivo animal model
体内动物模型中益生菌定植的分子机制的表征
  • 批准号:
    229670-2000
  • 财政年份:
    2002
  • 资助金额:
    $ 15.11万
  • 项目类别:
    Discovery Grants Program - Individual
Characterisation of an in-vivo thrombosis animal model of the antiphospholipid syndrome using Beta 2-GPI KO mice
使用 Beta 2-GPI KO 小鼠表征抗磷脂综合征体内血栓形成动物模型
  • 批准号:
    nhmrc : 209500
  • 财政年份:
    2002
  • 资助金额:
    $ 15.11万
  • 项目类别:
    NHMRC Project Grants
Characterisation of the molecular mechanisms of colonisation of probiotic bacteria in an in vivo animal model
体内动物模型中益生菌定植的分子机制的表征
  • 批准号:
    229670-2000
  • 财政年份:
    2001
  • 资助金额:
    $ 15.11万
  • 项目类别:
    Discovery Grants Program - Individual
Characterisation of the molecular mechanisms of colonisation of probiotic bacteria in an in vivo animal model
体内动物模型中益生菌定植的分子机制的表征
  • 批准号:
    229670-2000
  • 财政年份:
    2000
  • 资助金额:
    $ 15.11万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了